Skip to main content
. 2022 Jul 25;13:959726. doi: 10.3389/fmicb.2022.959726

Table 2.

Effects of CSPCM on CD4+ cells, CD8+ cells, and CD4+/CD8+ in mesenteric lymph nodes.

Group A B C D E
CD3+ (%) 98.64 ± 1.34# 13.26 ± 2.56* 99.6 ± 0.25# 99.77 ± 0.1# 99.48 ± 0.11#
CD4+ (%) 68.86 ± 4.7# 36.65 ± 8.63* 64.39 ± 6.86# 57.69 ± 9.39# 58.19 ± 9.45#
CD8+ (%) 18.18 ± 1.77 17.85 ± 2.84 21.29 ± 6.05 17.18 ± 1.4 14.71 ± 2.67
CD4+/CD8+ 3.79 ± 1# 2.08 ± 2.49* 3.26 ± 0.81 3.35 ± 1.67 3.97 ± 0.24#